What is known?
  1. During new coronavirus pandemic, among patients with a history of malignant tumours, lung cancer is the most common cancer, but patients with lung cancer have no higher incidence of malignant events.
  2. Cytotoxic therapies should be continued under the required isolation, multidisciplinary approach is necessary for these patients
  3. In a patient with respiratory symptoms, if the new coronary pneumonia is excluded, the initiation of required treatments for other infectious agents should not be delayed.
  4. For follow up patients telemedicine is a good alternative.